Summary for ARTG Entry:
CELMUNO mycophenolate mofetil 500 mg tablet blister pack
ARTG entry for
Arrow Pharma Pty Ltd
15 - 17 Chapel Street,Cremorne, VIC, 3121
ARTG Start Date
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. CELMUNO mycophenolate mofetil 500 mg tablet blister pack
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
Prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. ,Prophylaxis of organ rejection in paediatric patients (2 to 18 years)
receiving allogeneic renal transplants.
Additional Product information
Store below 25
Protect from Light
Pack Size/Poison information
(S4) Prescription Only Medicine
Tablet, film coated
Route of Administration
Lavender, convex, capsule-shaped tablet with "MO 500" on one side and
Arrow logo on the other side
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 29.11.2017 at 02:39:28 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information